ESHRE and ISAR Benchmarking: What UAE Fertility Clinics Should Actually Measure

Key Takeaways

• ESHRE and ISAR provide the most widely used international benchmarking frameworks for IVF performance
• Most indicators require age-stratified, per-cycle data with consistent denominator definitions
• UAE clinics often collect the right raw data but structure it in ways that make standard indicator calculation difficult
• The minimum viable dataset includes patient demographics, cycle characteristics, lab outcomes, and pregnancy results with follow-up
• Implementing these indicators enables valid international comparison and internal quality monitoring

If you run a fertility clinic in the UAE and someone asks you how your performance compares to international standards, what do you say?

Most clinic directors will mention their overall success rate. Some will compare their outcomes to a competitor or to published literature they've seen at conferences. A few will reference ESHRE or regional registry data.

Almost none of them are calculating the same indicators that ESHRE and ISAR registries actually use for benchmarking. Not because they don't want to. But because their data isn't structured to calculate those indicators correctly. And when the data structure doesn't match the indicator definitions, the comparison breaks.

This post walks through what ESHRE and ISAR benchmarking actually involves, which indicators matter most for clinical quality monitoring, and how to structure your UAE clinic data so that you can calculate them reliably.

What ESHRE and ISAR actually are

ESHRE is the European Society of Human Reproduction and Embryology. Among other things, it runs a Europe-wide ART registry that collects cycle-level data from participating clinics and publishes aggregated performance indicators. These indicators, things like cumulative live birth rate per started cycle, age-stratified clinical pregnancy rate, and fertilization rate by insemination method, have become the de facto international benchmarks for IVF performance.

ISAR, the International System for Assisted Reproduction Technology Surveillance, is a complementary framework developed to standardize ART data collection and reporting globally. It defines what should be measured, how denominators should be calculated, and how patient populations should be stratified. Many national registries, including some in the Middle East, now align their reporting with ISAR definitions.

The reason these frameworks matter for UAE clinics is that if you want to benchmark your performance against international standards, you need to be calculating the same indicators the same way. A "success rate" calculated differently from ESHRE's definition is not comparable to ESHRE's published benchmarks. And if your internal data structure doesn't support ISAR-aligned indicator calculation, you can't produce the numbers you need for valid comparison.

The six core indicators most clinics should be tracking

ESHRE and ISAR define dozens of potential indicators. You don't need all of them. But there are six that form the backbone of meaningful fertility clinic benchmarking. If your clinic can calculate these six reliably, you have the foundation for both internal quality monitoring and external comparison.

1. Live birth rate per started cycle, stratified by age group

This is the single most important patient-facing outcome. A started cycle is any cycle where ovarian stimulation was initiated, regardless of whether it proceeded to retrieval or transfer. The denominator includes cancellations. The numerator is deliveries resulting in at least one live-born infant.

Age stratification is mandatory. The standard ESHRE categories are under 35, 35 to 37, 38 to 39, 40 to 42, and 43 and older. Your clinic's overall live birth rate is interesting. But it's your age-stratified rates that determine whether your performance is in line with international benchmarks for comparable patient populations.

2. Clinical pregnancy rate per embryo transfer, stratified by embryo stage and age

This measures your transfer success rate specifically. The denominator is embryo transfers performed. The numerator is clinical pregnancies confirmed by ultrasound at 6 to 7 weeks. You should calculate this separately for day-3 embryo transfers and day-5/6 blastocyst transfers, because blastocyst transfers have systematically higher success rates.

This indicator is sensitive to embryo quality, endometrial receptivity, and transfer technique. A clinic with strong lab performance but weak transfer outcomes will see it reflected here.

3. Fertilization rate by insemination method

Fertilization rate is the proportion of retrieved mature oocytes that successfully fertilize. You calculate this separately for conventional IVF and for ICSI, because ICSI has a higher fertilization rate by design.

The denominator is metaphase II (mature) oocytes. The numerator is two-pronuclear embryos observed on day 1. If your clinic is reporting fertilization rate per total oocytes retrieved rather than per mature oocytes, you're understating your fertilization rate and the comparison to ESHRE benchmarks is invalid.

Fertilization rate is a direct measure of laboratory technique. A fertilization rate below 65% for ICSI or below 55% for conventional IVF is a quality signal worth investigating.

4. Blastulation rate (day-5/6 blastocyst formation per fertilized embryo)

This measures how many fertilized embryos develop to blastocyst stage by day 5 or day 6 of culture. It's one of the clearest indicators of embryology lab culture conditions and incubator stability.

The denominator is normally fertilized embryos on day 1. The numerator is usable blastocysts on day 5 or day 6. A blastulation rate below 40% suggests either suboptimal lab conditions or patient case mix with poor embryo quality. Stratifying by maternal age helps distinguish between the two.

5. Cycle cancellation rate by reason and stage

Not all cancellations are the same. A cycle cancelled for poor ovarian response reflects patient selection and stimulation protocol. A cycle cancelled for OHSS risk reflects protocol management. A cycle cancelled because no embryos formed reflects lab performance or oocyte quality.

ESHRE-aligned reporting breaks cancellations into: cancellation before retrieval (poor response or OHSS risk), cancellation after retrieval (failed fertilization), and cancellation after fertilization (no viable embryos for transfer). Each category points to a different part of the treatment pathway and requires a different response.

6. Cumulative live birth rate per patient

This is the proportion of patients who achieve at least one live birth within a defined time period or number of cycles, including fresh and frozen embryo transfers from the same oocyte retrieval.

Cumulative rates are more clinically meaningful than per-cycle rates, because many patients undergo multiple transfers from a single retrieval. A patient who doesn't achieve pregnancy on a fresh transfer but succeeds on a subsequent frozen transfer is a success in cumulative terms but a failure in per-fresh-cycle terms.

Calculating cumulative rates requires patient-level longitudinal tracking. Many UAE clinics track individual cycles but don't link multiple cycles from the same patient in a way that makes cumulative calculation straightforward. If your database isn't set up for this, your cumulative rate is either unavailable or calculated incorrectly.

How UAE clinic data usually breaks

Here's the thing: most UAE fertility clinics collect all the data points needed to calculate ESHRE and ISAR indicators. The problem is not missing data. It's how the data is structured.

The most common issues I see are:

Inconsistent denominator capture. The clinic records egg retrievals and embryo transfers but doesn't consistently flag which retrievals came from started cycles that cancelled before retrieval. Without that, you can't calculate per-started-cycle rates. You can only calculate per-retrieval rates, which aren't directly comparable to ESHRE's published per-cycle benchmarks.

Age recorded at retrieval rather than at cycle start. ESHRE indicators stratify by the patient's age at the start of treatment. If your system records age at the time of embryo transfer, and that transfer happens months after the initial retrieval, the age stratification is wrong. A 34-year-old patient who turns 35 before her frozen transfer gets placed in the wrong age category.

Pregnancy outcomes not linked back to the originating cycle. A frozen embryo transfer that results in live birth should contribute to the cumulative success rate of the original retrieval cycle. If your database treats the frozen transfer as a standalone event without linking it to the retrieval, your cumulative rate calculation is incomplete.

Lab metrics calculated at the wrong level of aggregation. Fertilization rate should be calculated per oocyte, blastulation rate per fertilized embryo, and implantation rate per embryo transferred. If these are being calculated at the cycle level or the patient level, the numbers are wrong and not comparable to benchmarks.

None of these are hard to fix structurally. But they require deliberate data architecture decisions. And if those decisions weren't made when the clinic's data system was set up, retrofitting them into the existing workflow takes time.

The minimum viable dataset for ESHRE/ISAR-aligned reporting

If you want to implement ESHRE and ISAR benchmarking indicators in your UAE clinic, here's what your dataset needs to include at minimum:

Patient demographics: Patient ID, date of birth, weight, height, BMI. Age should be calculated at cycle start, not at transfer.

Cycle characteristics: Cycle start date, indication for treatment, AMH level, antral follicle count, stimulation protocol, total FSH dose, trigger type, whether the cycle was cancelled and at what stage.

Oocyte retrieval outcomes: Number of oocytes retrieved, number of mature oocytes, insemination method per oocyte (IVF vs ICSI), fertilization result per oocyte.

Embryo development: Number of normally fertilized embryos on day 1, embryo grade on day 3 (if applicable), blastocyst formation on day 5/6, number of embryos transferred, number of embryos cryopreserved, embryo quality grade at transfer.

Pregnancy and birth outcomes: Pregnancy test result, clinical pregnancy confirmation (gestational sac on ultrasound), ongoing pregnancy at 12 weeks, delivery date, live birth (yes/no), number of live-born infants.

Longitudinal linkage: Each frozen embryo transfer must be linked back to its originating retrieval cycle. Each retrieval cycle must be linked to a unique patient ID so that cumulative outcomes can be calculated across multiple cycles and transfers.

This is not an exhaustive list. But it's the minimum required structure. If any of these elements are missing or inconsistently recorded, your ability to calculate standard indicators is compromised.

What implementing this looks like in practice

Setting up ESHRE/ISAR-aligned indicator reporting is not a one-time extract from your EMR. It's an ongoing data pipeline. Here's what a practical implementation involves:

First, audit your current data structure against the minimum dataset requirements above. Identify which fields are reliably populated, which are inconsistently captured, and which are missing entirely. This audit typically reveals 4 to 6 structural gaps that need to be addressed.

Second, implement the necessary data corrections. This might mean adding age-at-cycle-start as a calculated field, restructuring your embryo tracking so that fertilization and blastulation can be calculated per oocyte and per embryo rather than per cycle, or creating a linkage table that connects frozen transfers back to their originating retrievals.

Third, build the calculation logic for each indicator. This is where age stratification, denominator selection, and correct aggregation need to be implemented in code. A well-designed system will let you generate all six core indicators with a single query or report template, rather than requiring manual calculation each time.

Fourth, validate your calculated indicators against a sample of manually verified cycles. Take 50 recent cycles, calculate the indicators by hand, and compare the results to what your automated system produces. If there are discrepancies, trace them back to the source logic.

Finally, set up a reporting cadence. Monthly or quarterly calculation of all six indicators, with trend charts showing how your performance is changing over time. This is what turns benchmarking from a one-time exercise into a continuous quality monitoring system.